Lymphoma Treatment
淋巴瘤治疗
Duration
4-8 months for standard chemotherapy, varies for CAR-T
Recovery
Weeks between chemotherapy cycles, 1-3 months for CAR-T recovery
Savings
~91% vs US
Average savings compared to US prices
China's hematology-oncology centers provide comprehensive lymphoma treatment including R-CHOP and other immunochemotherapy regimens, CAR-T cell therapy for relapsed disease, and autologous stem cell transplant. China is a global leader in CAR-T therapy with multiple domestically approved products at a fraction of Western pricing. Patients with both Hodgkin and non-Hodgkin lymphoma benefit from multidisciplinary care and access to cutting-edge treatments.
Diagnosis & Subtyping
Excisional biopsy with immunohistochemistry, flow cytometry, and molecular studies classify lymphoma subtype
Duration: 3-5 daysStaging PET-CT
Full-body PET-CT and bone marrow biopsy determine disease stage and treatment approach
Duration: 2-3 daysImmunochemotherapy
Standard regimen (R-CHOP for DLBCL, ABVD for Hodgkin) delivered in 6-8 cycles
Duration: 4-6 monthsResponse Assessment & Consolidation
Interim and end-of-treatment PET-CT; CAR-T or stem cell transplant for refractory disease
Duration: Varies- Access to affordable CAR-T therapy ($40-60K vs $400-500K in US)
- Multiple China-approved CAR-T products for B-cell lymphomas
- High cure rates for many lymphoma subtypes
- Comprehensive supportive care during intensive treatment
- Immunosuppression increasing infection risk
- Chemotherapy-induced cardiotoxicity (doxorubicin)
- CAR-T cytokine release syndrome (CRS)
- Secondary cancers from chemotherapy or radiation
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.